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1  | INTRODUC TION
Diabetes mellitus (DM) is a global disease affecting millions of people 
and is ranked seventh leading cause of death (Danaei et al., 2011). DM 
has been associated with hyperglycemia, which is the primary cause of 
most diabetes complications (Shodehinde & Oboh, 2012). Oritz et al. 
(2007) reported that hyperglycemia is a condition of abnormal increase 
in plasma glucose level, and in type II diabetes mellitus is due to insulin 
resistance which may be due to a number of defects in signal trans-
duction ranging from abnormal insulin or insulin receptors to defects in 
glucose transporters. Persistent hyperglycemia can lead to increase gen-
eration of reactive oxygen species (ROS) with a decrease in endogenous 
antioxidants (Oritz et al., 2007). An effective approach for type II diabe-
tes mellitus management has been through inhibitions of pancreatic α- 
amylase and intestinal α- glucosidase enzymes as documented by Krentz 
and Bailey (2005). Kwon, Vattem, and Shetty (2006) reported that intes-
tinal α- glucosidase inhibition, delays the absorption of glucose, moder-
ates postprandial blood glucose elevation, and thus mimics the effects 
of dieting on hyperglycemia. Also, amylase inhibition may be useful in 
the management of type II diabetes mellitus and obesity (Custódio et al., 
2015). However, acarbose, miglitol, and voglibose which are drugs cur-
rently used as α- amylase and α- glucosidase inhibitors demonstrate side 
effects such as abdominal distension, bloating, meteorism, and flatu-
lence (Chakrabarti & Rajagopalan, 2002). Therefore, natural inhibitors 
 
Received:	27	December	2017  |  Revised:	29	June	2018  |  Accepted:	29	June	2018
DOI:	10.1002/fsn3.749
O R I G I N A L  R E S E A R C H
In vitro antioxidant activities and inhibitory effects of phenolic 
extract of Senecio biafrae (Oliv and Hiern) against key enzymes 
linked with type II diabetes mellitus and Alzheimer’s disease
Basiru O. Ajiboye1  | Oluwafemi A. Ojo1  | Marry A. Okesola1 | Ayodele J. Akinyemi1 |  
Justina Y. Talabi2 | Olajumoke T. Idowu1 | Adewale O. Fadaka1 | Aline A. Boligon3 |  
Marli M. Anraku de Campos3
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, 
provided the original work is properly cited.
© 2018 The Authors. Food Science & Nutrition published by Wiley Periodicals, Inc.
1Department of Chemical Sciences, Afe 
Babalola University, Ado-Ekiti, Nigeria
2Department of Human Nutrition and 
Dietetics, Afe Babalola University, Ado-Ekiti, 
Nigeria
3Graduate Program in Pharmaceutical 
Sciences, Federal University of Santa Maria, 
Santa Maria, Brazil
Correspondence
Basiru O. Ajiboye, Department of Chemical 
Sciences, Afe Babalola University, Ado-Ekiti, 
Ekiti State, Nigeria.
Emails: ajiboyebo@abuad.edu.ng; 
bash1428@yahoo.co.uk
Abstract
The phenolic extract of Senecio biafrae leaves was investigated to determine the in 
vitro antioxidant, phenolic profiles, and inhibition of key enzymes relevant to type II 
diabetes mellitus (α- amylase and α- glucosidase) and Alzheimer’s disease (acetylcho-
linesterase and butrylcholinesterase). The phenolic extract demonstrated significant 
scavenging abilities against all in vitro antioxidant parameters assessed. Reversed- 
phase HPLC of the extract revealed the presence of gallic acid, chlorogenic, caffeic 
acid, rutin, quercetin, and kaempferol. The extract also inhibited activities of α- 
amylase (IC50	=	126.90	μg/ml), α- glucosidase (IC50	=	139.66	μg/ml), acetylcholinest-
erase (IC50 = 347.22 μg/ml), and butrylcholinesterase (IC50	=	378.79	μg/ml), which 
may be attributed to the antioxidant potential of the extract and its phenolic compo-
sition. Therefore, this study suggests that the leaves of S. biafrae may be useful in the 
management of diabetes mellitus and Alzheimer’s disease.
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from dietary plants inhibited both α- amylase and α - glucosidase and can 
be used as remedy for postprandial hyperglycemia with no or minimal 
side effects (Kwon et al., 2006; Shodehinde & Oboh, 2012).
Alzheimer’s disease (AD) accounts for 60%–80% of all cases of de-
mentia, and it has no cure and is the fourth leading cause of death in 
developed nations, after heart disease, cancer, and stroke (Custódio 
et	al.,	2015).	According	to	Alzheimer’s	Disease	International	 (2009),	
more than 36 million people in 2010 are suffering from AD, and it 
has been projected that more than 66 million people will be suffering 
from AD by 2030, if necessary actions are not taken. AD has been de-
scribe by a reduction in the levels of the neurotransmitteracetylcho-
line (ACh), which is hydrolyzed mainly by acetylcholinesterase (AChE) 
and then by butrylcholinesterase (BuChE) (Racchi, Mazzucchelli, 
Porrello, Lanni, & Govoni, 2004). Moreover, the inhibition of AChE 
is currently the most established approach for the management of 
AD, and numerous AChE inhibitors (AChEI) are used to attenuate the 
symptoms associated with this disease (such as tacrine, donzepil, and 
galanthamine) as reported by Orhan, Kartal, Tosun, and Sener (2007). 
However, these AChEI are characterize with hepatotoxicity, dizzi-
ness, vomiting, and diarrhea among others, and this drives the needs 
to search for novel and safer therapy (Custódio et al., 2015).
Alam et al. (2014) reported that AD is related to type II diabetes 
mellitus (T2D) and that both diseases share the same pathophysiol-
ogy, leading to the hypothesis that AD might be type III diabetes. This 
is based on emerging similarities between the two diseases, which 
include protein conformational disorders; association with obesity, 
insulin resistance, inflammation, and endoplasmic reticulum stress; 
en- route initiation; and/or stage aggravation (Priyadarshini, Kamal, & 
Nigel, 2012). Patients with hyperinsulinemia, insulin resistance and 
T2D are at an increased risk of memory impairment and AD (Kroner, 
2009).	Thus,	Nagarani	et	al.	(2014)	reported	that	antidiabetic	drugs	
might be beneficial in treating patients with AD.
Senecio biafrae (Oliv and Hiern), called “worowo” in the Western 
part of Nigeria, is a vegetable; grown mostly under cocoa tree planta-
tion. This plant leaf is believed to be endowed with medicinal proper-
ties (Ajiboye et al., 2014). Ajiboye, Ibukun, Edobor, Ojo, and Onikanni 
(2013) documented the phytochemical constituents of the plant’s 
leaf, with high content of phenolic compounds. The uses of phenolic 
extract of S. biafrae leaf in vitro in the management of type II diabetes 
mellitus and Alzhimer’s disease are scanty in the literature. Therefore, 
this study was designed to investigate the antioxidant effect and pos-
sible inhibition against key enzymes linked to type II diabetes mellitus 
(α- amylase and α- glucosidase) and Alzheimer’s disease (acetylcholin-
esterase and butrylcholinesterase) of the plant phenolic extract.
2  | MATERIAL S AND METHODS
2.1 | Plant material
Fresh sample of S. biafrae leaf was purchased from Oja Oba Market 
in Ado- Ekiti, Ekiti State, Nigeria. The plant was identified and au-
thenticated at the herbarium unit of the Plant Biology, Ekiti State 
University, Nigeria with voucher specimen number UHAE 138. The 
plant sample was washed with distilled water and shade- dried for 
2 weeks at 25°C. Thereafter, it was ground to a fine powder, and 
stored in the refrigerator before phenolic extraction.
2.2 | Preparation of phenolic extract
Fifty grams of the powdered sample was extracted with 80% acetone 
(1:5 w/v) and filtered. The filtrate was evaporated using a rotary evapo-
rator	under	vacuum	at	45°C	until	90%	of	the	filtrate	had	been	dried	and	
subsequently lyophilized to obtain dry weight extract. The extract was 
kept in a freezer prior to further analysis (Chu, Sun, Wu, & Liu, 2002).
2.3 | Determination of total phenolic content
Appropriate dilutions of the extracts were oxidized with 2.5 ml of 
10% Folin- Ciocalteau’s reagent (v/v) and neutralized by 2.0 ml of 
7.5% sodium carbonate. The reaction mixture was incubated for 
40 min at 45°C and the absorbance was read at 765 nm (Singleton, 
Orthofer,	&	Lamuela,	1999).	The	total	phenol	content	was	calculated	
using gallic acid as the standard.
2.4 | Determination of total flavonoid content
Briefly, 0.5 ml of appropriately diluted extract was mixed with 0.5 ml 
of methanol, 50 μl of 10% AlCl3, 50 μl of 1 M potassium acetate and 
1.4 ml of distilled water. This was incubated at room temperature for 
30 min and subsequently measured at 415 nm. The total flavonoid 
was calculated using quercetin as standard (Meda, Lamien, Romito, 
Millogo, & Nacoulma, 2005).
2.5 | HPLC- DAD analyses
Senecio biafrae extracts at 10 mg/ml were injected onto reversed- 
phase Phenomenex C18 column (4.6 mm × 250 mm) packed with 
5 μm diameter particles. The mobile phases were 0.5% (v/v) aqueous 
formic acid (solvent A) and 1% (v/v) acetic acid in acetonitrile (solvent 
B). The binary elution system was as follows: 2% B for 5 min to wash 
the column, a linear gradient was 8% B (25 min), 12% B (45 min), 24% 
B (60 min). After 80 min, the organic phase concentration was re-
duced to 2% (B) and lasted 10 min for column equilibration. Flow 
rate of 0.6 ml/min and injection volume of 40 μl (Carvalho et al., 
2016) were used. Quantifications were carried out by integration of 
the peaks using the external standard method, at 254 nm for gallic 
acid, 327 nm for chlorogenic and caffeic acid, and 366 nm for rutin, 
quercetin and kaempferol. The extract and mobile phase was filtered 
through 0.45 μm membrane filter (Millipore) and then degassed by 
ultrasonic bath prior to use. Stock solutions of standards references 
were prepared in the HPLC mobile phase at a concentration range 
of 0.025–0.300 mg/ml. Chromatography peaks were confirmed by 
comparing retention times with those of reference standards and by 
DAD spectra (200–700 nm). All chromatography operations were 
carried out at ambient temperature in triplicate.
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2.6 | 2,2-diphenyl-1-picrylhydrazyl (DPPH) free 
radical scavenging ability
Briefly, 1 ml of the extract was mixed with 1 ml of 0.4 mM metha-
nolic solution containing DPPH radicals. Then, the mixture was left 
in a dark for 30 min and the absorbance was measured at 516 nm 
(Gyamfi,	Yonamine,	&	Aniya,	1999).
2.7 | 2,2'-azobis-3-ethylbenzothiazoline-6-sulfonate 
(ABTS) radical scavenging ability
The	method	of	Re	et	al.	(1999)	was	employed.	ABTS	was	generated	
by reacting 7 mM of ABTS aqueous solution with K2S2O8 (2.45 mM, 
concentration) in the dark for 16 hr and adjusting the absorbance 
at 734 nm to 0.70 with ethanol. Thereafter, 0.2 ml of appropriate 
dilution of the extract was added to 2.0 ml ABTS solution and the 
absorbance was measured at 734 nm after 15 min.
2.8 | Hydroxyl radical scavenging ability
The hydroxyl radical scavenging activity of the extract was deter-
mined	by	 the	method	of	Halliwell,	Gutteridge,	 and	Aruoma	 (1987).	
Briefly, various concentrations of the extracts were mixed with 1 ml 
of reaction mixture (100 μM FeCl3, 104 μM EDTA, 1.5 mM H2O2, 
2.5 mM deoxyribose and 100 μM ascorbic acid in 10 mM KH2PO4–
KOH, pH7.4) and incubated for 1 hr at 37°C. Thereafter, 1 ml of 0.5% 
TBA in 0.025N NaOH and 1 ml of 2.8% TCA was added to the mix-
ture and heated for 30 min at 80°C, before reading the absorbance 
at 532 nm.
2.9 | Ferric reducing antioxidant property
The	method	described	by	Oyaizu	(1986)	was	used.	In	total,	2.5	ml	ali-
quot was mixed with 2.5 ml 200 mM sodium phosphate buffer (pH 6.6) 
and 2.5 ml 1% potassium ferricyanide. The mixture was incubated at 
50°C for 20 min and then 2.5 ml 10% trichloroacetic acid was added. 
This mixture was centrifuged at 650 rpm for 10 min. Thereafter, 5 ml 
of the supernatant was mixed with an equal volume of water and 1 ml 
0.1% ferric chloride. The absorbance was measured at 700 nm.
2.10 | Fe2+ chelating assay
The method of Puntel, Nogueira, and Rocha (2005) was employed. Briefly, 
150 μl of freshly prepared 500 μM FeSO4 was added to a reaction mix-
ture containing 168 μl of 0.1 M Tris- HCl (pH 7.4), 218 μl saline and the 
extract at different concentrations. The reaction mixture was incubated 
for 5 min, before addition of 13 μl of 0.25% 1.10- Phenanthroline (w/v). 
The absorbance was measured at 510 nm in the spectrophotometer.
2.11 | NO radical scavenging ability
The reaction mixture (3 ml) containing sodium nitroprusside (10 mM) 
in phosphate buffered saline (PBS) and the extract at different 
concentrations were incubated at 25°C for 150 min. At every 30 min 
interval, 0.5 ml of the incubated sample was removed and 0.5 ml 
of Griess reagent (1% sulfanilamide, 0.1% naphthylethylene di-
amine dihydrochloride in 2% H3PO4) was added. The absorbance 
of the chromophore formed was measured at 546 nm (Mondal, 
Chakraborty, Gupta, & Muzumdar, 2006).
2.12 | α- Amylase inhibitory activity
This was determined according to the method of Worthington 
(1993).	Phenolic	extract	dilutions	of	0–150	μl and 500 μl of 0.02 M 
sodium	phosphate	buffer	(at	pH	of	6.9	with	6	mM	NaCl)	contain-
ing porcine pancreatic amylase (EC 3.2.1.1) (0.5 mg/ml) were incu-
bated at 25°C for 10 min. Thereafter 500 μl of 1% starch solution 
in	 0.02	M	 sodium	 phosphate	 buffer	 (pH	 6.9	 with	 6	mM	 NaCl)	
was added to each tube. The reaction mixture was incubated 
at 25°C for 10 min and stopped with the addition of dinitrosali-
cylic acid (DNSA). The mixture was then incubated in a boiling 
water bath for 5 min and cooled at room temperature (24 ± 1°C). 
Finally, 10 ml of distilled water was added to the reaction mixture, 
and	 absorbance	was	 read	 at	 540	nm	 in	 the	 JENWAY	UV-	Visible	
spectrophotometer.
2.13 | α-Glucosidase inhibitory activity
This was carried out according to the method of Apostolidis, 
Kwon, and Setty (2007). Phenolic extract dilutions of 1–150 and 
100 μl of α- glucosidase (EC 3.2.1.20) solution (1.0 U/ml) in 0.1 M 
phosphate	 buffer	 (pH	 6.9)	 were	 incubated	 at	 25°C for 10 min. 
Thereafter, 50 μl of 5 mM para- nitrophenyl- α- D- glucopyranoside 
solution	 (pNPG)	 in	 0.1	M	 phosphate	 buffer	 (pH	 6.9)	 was	 added.	
Finally, the reaction mixture was incubated at 25°C for 5 min, be-
fore	reading	the	absorbance	at	405	nm	in	the	JENWAY	UV-	Visible	
spectrophotometer.
2.14 | Acetylcholinesterase and 
butyrylcholinesterase inhibitory activities
Inhibition of AChE was determined by a modified colorimetric 
method	 of	 Ellman,	 Courtney,	 Andres,	 and	 Featherstone	 (1961).	
The AChE activity was determined in a reaction mixture contain-
ing 200 μl of a solution of AChE (0.415 U/ml in 0.1 M phosphate 
buffer, pH 8.0), 100 μl of a solution of 5,5- dithiobis(2- nitrobenzoic) 
acid (3.3 mM DTNB in 0.1 M phosphate buffered solution, pH 
7.0, containing 6 mM NaHCO3), 30 μl the plant extract and 500 μl 
of phosphate buffer, pH 8.0. After incubation for 20 min at 25°C, 
100 μl of 0.05 mM acetylthiocholine iodide solution was added as 
substrate, and AChE activity was determined as changes in absorb-
ance at 412 nm for 3 min at 25°C using a spectrophotometer. 100 μl 
of butyrylthiocholine iodide was used as substrate to assay butyryl-
cholinesterase activity, while all other reagents and conditions were 
the same. The AChE and BChE inhibitory activities were expressed 
as percentage inhibition.
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2.15 | Data analysis
All data were expressed as the mean ± standard error of means 
(SEM). Differences were assessed by a one- way analysis of variance 
(ANOVA) followed by the post hoc LSD test for analysis of biochemi-
cal data using SPSS version 10.0 (SPSS Inc., Chicago, IL, USA) statis-
tical software. p < 0.05 was considered statistically significant, while 
differences between groups of HPLC were assessed by an analysis 
of variance model and Tukey’s test. The level of significance for the 
analyses was set to p < 0.05. These analyses were performed using 
the	free	software	R	version	3.1.1	(Zar,	1984).
3  | RESULTS
The quantification of total phenol and total flavonoid of S. biafrae 
leaf are presented in Table 1. The total phenol content was signifi-
cantly (p < 0.05) higher than total flavonoid.
The HPLC fingerprinting of the phenolic extract (Figure 1 and 
Table 2) revealed the presence of gallic acid (retention time- tR = 
9.85	min,	peak	1),	chlorogenic	acid	(tR = 22.07 min, peak 2), caffeic 
acid (tR = 25.01 min, peak 3), rutin (tR = 40.13 min, peak 4), quercetin 
(tR	=	48.59	min,	peak	5)	and	kaempferol	(tR = 60.15 min, peak 6). The 
HPLC analysis also revealed that the flavonoids (like quercetin, rutin 
and kaempferol) and phenolic acids (such as chlorogenic, gallic and 
caffeic acids) were the components of the extract.
The free radical scavenging abilities are presented in Figures 2–6 
and Table 3. The extract demonstrated inhibitory abilities against all 
free radicals in concentration- dependent manner with IC50 (Table 4) 
ranging from 65.02 to 127.23 μg/ml.
The phenolic extract also demonstrated significant (p < 0.05) 
inhibitory activities against α- amylase and α- glucosidase (Figures 7 
and 8) with IC50	(Table	4)	between	126.90	and	139.66	μg/ml, respec-
tively.	Figures	9	and	10	show	the	inhibitory	activities	against	acetyl-
cholinesterase and butylrycholinestearse. The results showed that 
the extract was able to inhibit acetylcholinesterase and butylrycho-
linestearse in concentration- dependent manner with IC50 of 347.22 
and	378.79	μg/ml, respectively.
4  | DISCUSSION
The antioxidative potential of phenolic compounds in protecting 
human body system from free radicals, has been reported by Saliu 
and Olabiyi (2017). The phenolics in the extract were capable of 
removing free radicals, chelate metallic catalysts, activate antioxi-
dant enzymes, reduce alpha tocopherol radicals and inhibit oxidases 
(Amic, Davidovic, Beslo, & Trinajstic, 2003). They may also contrib-
ute to the quality of food by modifying taste, aroma, color and flavor 
TABLE  1 Total phenol and total flavonoids of phenolic extract of 
Senecio biafrae leaf
Total phenol (mg gallic acid 
equivalent/100 g dry weight 
extract)
Total flavonoid (mg quercetin 
equivalent/100 g dry weight 
extract)
201.26 ± 1.47b 41.19	±	2.16a
Note. Values represent mean ± standard error of means (SEM) of tripli-
cate readings.
Values with difference superscript across the row are significantly differ-
ent (p > 0.05).
F IGURE  1 High- performance liquid chromatography phenolics 
and flavonoids profile of Senecio biafrae extract. Gallic acid (peak 1), 
chlorogenic (peak 2), caffeic acid (peak 3), rutin (peak 4), quercetin 
(peak 5), and kaempferol (peak 6)
TABLE  2 Phenolic compositions of Senecio biafrae extract by 
HPLC- DAD
Compounds Quantity (mg/g)
Gallic acid 1.46 ± 0.01c
Chlorogenic acid 2.73 ± 0.03e
Caffeic acid 3.11 ± 0.10f
Rutin 0.65 ± 0.11b
Quercetin 1.85 ± 0.02d
Kaempferol 0.36 ± 0.04a
Note. Results are expressed as mean ± SEM of three determinations.
Different letters in each column represent significant differences 
(p < 0.05).
F I G U R E  2 DPPH free radical scavenging ability of phenolic 
extract of Senecio biafrae leaf.Values are represented as mean ± 
SEM of triplicate experiments
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(Memnune	 et	al.,	 2009).	 According	 to	 Oboh	 (2006),	 the	 phenolic	
constituents of plants are antioxidants capable of preventing the 
production of free radicals and/or scavenging free radicals produced 
in the body. The presence of flavonoids and phenolics (gallic acid, 
chlorogenic, caffeic acid, rutin, quercetin and kaempferol) in the ex-
tract may also contribute to lowering cellular oxidative stress and 
inhibit α- amylase, α- glucosidase, acetylcholinesterase and butylry-
cholinesterase activities (Adefegha & Oboh, 2015).
F I G U R E  3 ABTS free radical scavenging ability of phenolic 
extract of Senecio biafrae leaf. Values are represented as mean ± 
SEM of triplicate experiments
F I G U R E  4 OH radical scavenging ability of phenolic extract 
of Senecio biafrae leaf. Values are represented as mean ± SEM of 
triplicate experiments
F I G U R E  5 Fe2+ chelating ability of phenolic extract of Senecio 
biafrae leaf. Values are represented as mean ± SEM of triplicate 
experiments
F I G U R E  6 NO scavenging ability of phenolic extract of Senecio 
biafrae leaf. Values are represented as mean ± SEM of triplicate 
experiments
TABLE  3 Ferric reducing antioxidant power (FRAP) (ascorbic 
acid equivalent mg/100 g) of Senecio biafrae extract
Extract Inhibitory
Phenolic extract of S. biafrae 474.25 ± 2.23
Note. Values are represented as mean ± SEM of triplicate experiments.
TABLE  4  IC50 values for the in vitro antioxidant properties and 
enzymes inhibitory ability of phenolic extract of Senecio biafrae leaf
IC50 
values 
(μg/ml)
Fe2+ chelating ability 118.76
OH radical scavenging ability 65.02
ABTS radical scavenging ability 78.25
DPPH free radical scavenging ability 92.08
NO radical scavenging ability 127.23
α- Amylase inhibition 126.90
α- Glucosidase inhibition 139.66
Acetylcholinesterase inhibition 347.22
Butrylrycholinesterase inhibition 378.79
F I G U R E  7  Inhibitory activities of phenolic extract of Senecio 
biafrae leaf against alpha- amylase. Values are represented as mean 
± SEM of triplicate experiments
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Furthermore, Alam et al. (2014) documented that there is a 
link between the pathogenesis of type II diabetes mellitus and 
Alzheimer’s disease with free radical. Plant bioactive compounds like 
phenolics, as observed in this study, may be useful for prevention 
and management of both type II diabetes mellitus and Alzheimer’s 
disease, due to antioxidant nature of the extract.
Hydroxyl radicals are highly reactive and capable of damaging 
biomolecules (Adefegha & Oboh, 2015) via lipid peroxidation of bi-
ological membrane and damage to DNA. Hence the results indicate 
that the phenolics in the extract have scavenging properties. FRAP 
results in this study, demonstrate antioxidant activity of the extract. 
This property may enable the extract to mop up toxic metabolites 
released during pathological states and confer protection on the af-
fected organs (Ajiboye et al., 2016).
Chelating iron might be useful in preventing generation of hy-
droxyl radicals. Oboh, Raddatz, and Henle (2008) reported that iron 
may serve as a metal catalyst in producing hydroxyl radicals from 
H2O2. The results of the present study showed that the extract 
chelated Fe2+, indicating that the generation of hydroxyl radicals in 
Fenton reaction can be attenuated and possible damage to biomole-
cules may be prevented.
Sivakumar, Mohandass, and Devika (2012) reported that nitric 
oxide is a free radical produced in mammalian cells, involved in the 
regulation of various physiological processes. Whereas, excess pro-
duction of NO is associated with several diseases (e.g., diabetes mel-
litus, Alzheimer’s disease, cancer, etc.). The results showed nitrite 
production was reduced by the phenolic extract (gallic acid, chloro-
genic, caffeic acid, rutin, quercetin, and kaempferol).
Abirami, Nagarani, and Siddhuraju (2014) reported that diabe-
tes mellitus is characterized by high concentration of blood sugar 
which can cause serious complications in the kidneys, liver, eyes, 
brain and cardiovascular system. The treatment of diabetes mellitus 
(especially in type II) focus mainly on reducing fluctuations in blood 
sugar and its complications (Sharifi- Rad et al., 2016). Therefore, in-
hibition of enzymes involved in the metabolism of carbohydrates, 
mainly α- amylase and α- glucosidase are key therapeutic approaches 
for decreasing hyperglycemia (Sharifi- Rad et al., 2016). In this study, 
the phenolic extract strongly inhibited α- amylase and α- glucosidase. 
This may suggest that inhibition activities against α- amylase and α- 
glucosidase could be part of the possible mechanisms of the phe-
nolic extract in dietary management of diabetes, by retarding the 
starch and oligosaccharides hydrolysis in the gastrointestinal tract. 
This would in turn cause a decrease in the absorption of glucose 
and consequently inhibit the increase in postprandial blood glucose 
(Krentz & Bailey, 2005). These dual inhibitory potentials against the 
target enzymes might be due to the presence of phenolics and fla-
vonoids (gallic acid, chlorogenic, caffeic acid, rutin, quercetin, and 
kaempferol) in the plant extract used.
Oxidative stress has been implicated in the pathogenesis and 
progression of Alzheimer’s disease, with loss of cholinergic neu-
rons in the brain (Saliu & Olabiyi, 2017). The results revealed that 
leaf extract inhibited both AChE and BChE activities. The inhibi-
tions of AChE and BChE activities have been established as an 
effective strategy for treatment of Alzheimer’s disease (Howes, 
Perry, & Houghton, 2003). Oboh, Agunloye, Akinyemi, Ademiluyi, 
F I G U R E  8  Inhibitory activities of phenolic extract of Senecio 
biafrae leaf against alpha- glucosidase. Values are represented as 
mean ± SEM of triplicate experiments
F I G U R E  9 Acetylcholinesterase inhibition by phenolic extract 
of Senecio biafrae leaf. Values are represented as mean ± SEM of 
triplicate experiments
F I G U R E  1 0 Butylrylcholinesterase inhibition by phenolic 
extract of Senecio biafrae leaf. Values are represented as mean ± 
SEM of triplicate experiments
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and Adefegha (2012) reported that inhibition of AChE and BChE 
activity prevents it from breaking down acetylcholine and butyr-
ylcholine in the brain to increase the concentrations of the neu-
rotransmitters at the synaptic cleft. This in turn leads to increase 
communication between the nerve cells consequently improving 
or stabilizing symptoms of Alzheimer’s disease. Orhan et al. (2007) 
reported that cholinesterase inhibitory effect of polyphenolic 
compounds is a function of number and position of their hydroxyl 
(OH) groups that forms hydrogen bonds with specific amino acids 
at the enzymes active sites. Therefore, inhibition of AChE and 
BChE by phenolic extract of S. biafrae leaf indicates neuroprotec-
tive ability of the extract which may be attributed to gallic acid, 
chlorogenic, caffeic acid, rutin, quercetin and kaempferol in the 
extract (Oboh et al., 2016).
5  | CONCLUSION
The various concentrations of phenolic extract of S. biafrae leaf 
demonstrate that they not only possess antioxidant and free radi-
cal scavenging activities but also exhibit inhibitory potential against 
α- amylase, α- glucosidase, acetylcholinesterase, and butyrylcho-
linesterase. Thus, this extract may be promising for the therapeutic 
approach in the management of both type II diabetes mellitus and 
Alzheimer’s disease due to its neutraceutical potentials.
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